Ginsenoside CK was also reported to inhibit the growth, migration and invasion, and survival of human osteosarcoma cells by triggering apoptosis and interfering with the PI3K/mTOR/p70S6K1 signaling pathway [66]. Here, RPS6KB1 is linked to osteosarcoma.